Laronidase Intravenous and Pms-Sodium Polystyrene Sulfonate
Determining the interaction of Laronidase Intravenous and Pms-Sodium Polystyrene Sulfonate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: laronidase
Brand name: Aldurazyme
Synonyms: Laronidase
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Laronidase Intravenous-Pneumococcal 13-valent conjugate vaccine
- Laronidase Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Laronidase Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Laronidase Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Laronidase Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Laronidase Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent
- Pms-Sodium Polystyrene Sulfonate-Larotrectinib
- Pms-Sodium Polystyrene Sulfonate-Larotrectinib Capsules
- Pms-Sodium Polystyrene Sulfonate-Larotrectinib Oral Solution
- Pms-Sodium Polystyrene Sulfonate-Larotrectinib Sulfate
- Pms-Sodium Polystyrene Sulfonate-Lartruvo
- Pms-Sodium Polystyrene Sulfonate-Larynex